[Antibiotic prophylaxis in colon surgery with Cefazolin]

Area of Science:

• Surgical infection prevention
• Clinical pharmacology
• Colorectal surgery outcomes

Background:

• Postoperative wound infections are a significant complication in colorectal surgery.
• Reducing surgical site infections (SSIs) is crucial for patient recovery and healthcare costs.

Purpose of the Study:

• To evaluate the efficacy of prophylactic Cefazolin in preventing postoperative wound infections after elective colorectal surgery.
• To assess the impact of Cefazolin on patient hospital stay.

Main Methods:

• Prospective, randomized, controlled, double-blind trial design.
• Systemic administration of Cefazolin as a prophylactic measure.
• Comparison of wound infection rates and hospital stay between Cefazolin-treated and control groups.

Main Results:

• A significant reduction in wound infection incidence from 32% in the control group to 10% in the Cefazolin-treated group (P < 0.01).
• A significant decrease in hospital stay by approximately 3 days for patients receiving Cefazolin (P < 0.05).

Conclusions:

• Prophylactic systemic Cefazolin is effective in reducing postoperative wound infections in elective colorectal surgery.
• Cefazolin administration can lead to shorter hospital stays, potentially improving resource utilization and patient recovery.